Drug Development and Industrial Pharmacy

Papers
(The H4-Index of Drug Development and Industrial Pharmacy is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
In vivo behavior of technetium-99m labeled ibuprofen in infection and inflamation animal models31
Establishing virtual bioequivalence and bio-related dissolution specifications for naproxen using physiologically based pharmacokinetic modeling and in vitro biorelevant30
Development and characterization of 3D printed ethylene vinyl acetate (EVA) as drug delivery device for the treatment of overactive bladder28
Microneedle-assisted transdermal delivery of amlodipine besylate loaded nanoparticles25
Preparation and evaluation of liposome with ropivacaine ion-pairing in local pain management22
Formulation, biopharmaceutical evaluation and in-vitro screening of polyherbal phytosomes for breast cancer therapy19
Construction of albumin-based nanoparticles utilizing paclitaxel-fatty acid prodrug that mimicking the natural fatty-acid binding process in vivo to syne18
A QbD approach for optimizing the lyophilization parameters of cyclophosphamide monohydrate18
Crisaborole loaded nanoemulgel for the mitigation of atopic dermatitis in mice model18
Polymeric oral fast dissolving films of metformin: fabrication, optimization, in vitro, and in vivo evalua18
Radioprotective effect of nanoniosome loaded by Mentha Pulegium essential oil on human peripheral blood mononuclear cells exposed to ionizing radiation17
Improving cellular uptake and synergetic anti-tumor effects of magnolol and Brucea javanica oil through self-microemulsion16
Ginkgolic acid as a fusion inhibitor: targeting RBD-ACE2 interaction with in silico, in vitro evidence of allosteric modulation and potent virucidal effect15
Intranasal delivery of metal/metal oxide nanoparticles for the management of CNS-related diseases: theranostic and toxicity issues15
Polymyxin B and silver nanoparticles: a nanotechnology-driven approach to overcome antibiotic resistance15
Studies on ameliorative potentials of quercetin nanoparticles against imidacloprid induced subacute genotoxicity and histopathological alteration in Swiss albino mice15
0.29824018478394